|
Re: Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
3
|
Resverlogix Corp.
|
Aug 04, 2020 10:47AM
|
|
Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
3
|
Resverlogix Corp.
|
Aug 04, 2020 10:38AM
|
|
Re: New RVX Tweet
|
7
|
Resverlogix Corp.
|
Aug 04, 2020 10:35AM
|
|
Re: New RVX Tweet
|
2
|
Resverlogix Corp.
|
Jul 31, 2020 01:31PM
|
|
Bioasis: An Emerging Medical Market Play with Great Opportunity
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jul 31, 2020 11:01AM
|
|
Re: Name Confusion
|
4
|
Zenith Epigenetics
|
Jul 29, 2020 01:21PM
|
|
Re: Name Confusion
|
3
|
Zenith Epigenetics
|
Jul 29, 2020 11:36AM
|
|
Re: Thinking back on an older discussion and wishing we had an update - Few items
|
6
|
Resverlogix Corp.
|
Jul 29, 2020 10:26AM
|
|
Re: Epigenetic Therapeutic Targets Virtual Summit Presentation July 28, 2020
|
4
|
Resverlogix Corp.
|
Jul 29, 2020 10:22AM
|
|
Re: Epigenetic Therapeutic Targets Virtual Summit Presentation July 28, 2020
|
6
|
Resverlogix Corp.
|
Jul 29, 2020 10:06AM
|
|
Zenith Epigenetics Advances ZEN-3694 in Multiple Cancer Programs
|
4
|
Zenith Epigenetics
|
Jul 29, 2020 09:59AM
|
|
Re: Epigenetic Therapeutic Targets Virtual Summit Presentation July 28, 2020
|
7
|
Resverlogix Corp.
|
Jul 29, 2020 09:57AM
|
|
Re: Thinking back on an older discussion and wishing we had an update - Few items
|
5
|
Resverlogix Corp.
|
Jul 28, 2020 10:37PM
|
|
Epigenetic Therapeutic Targets Virtual Summit Presentation July 28, 2020
|
5
|
Resverlogix Corp.
|
Jul 28, 2020 10:27PM
|
|
Resverlogix Announces Extension of its Filing Calendar Based on Continuous Disclosure Exemption
|
2
|
Resverlogix Corp.
|
Jul 28, 2020 10:24PM
|
|
Re: Zenith ZEN-3694/Enzalutamid... mCRPC Phase 1b/2a Study Published
|
7
|
Zenith Epigenetics
|
Jul 28, 2020 10:09PM
|
|
Epigenetic Therapeutic Targets Virtual Summit Presentation July 28, 2020
|
5
|
Zenith Epigenetics
|
Jul 28, 2020 10:05PM
|
|
Zenith ZEN-3694/Enzalutamid... mCRPC Phase 1b/2a Study Published
|
5
|
Zenith Epigenetics
|
Jul 28, 2020 10:52AM
|
|
Re: For Scientists - Nature article/study on epigenetic changes after kidney injury
|
3
|
Resverlogix Corp.
|
Jul 28, 2020 10:45AM
|
|
Re: Thinking back on an older discussion and wishing we had an update - Few items
|
4
|
Resverlogix Corp.
|
Jul 28, 2020 10:44AM
|
